- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02626273
ADIposity and Bone Metabolism: Effects of eXercise-induced Weight Loss in Obese Adolescents (ADIBOX)
The present protocol is mainly involved in the understanding of the local interaction between the released products by fat tissue and hormones production of bone tissue. These complex interactions between adipocyte and osteocyte activities could explain the mechanisms of the body responses to the strategies of weight loss that include diet and/or physical activity program, as well as the side effects encountered by these interventions.
Adolescence is a period of development characterized by many metabolic and somatic changes that may influence weight. Weights bearing physical activities are a key factor allowing body composition changes (i.e. fat and bone tissue). The difficulties of managing weight and the onset of overweight and obesity during this very important growth spurt lead to various hormonal dysregulation. The specific mechanisms of the evolution and interactions between these two parameters (fat and bone tissue) are not yet elucidated; therefore our aim is to analyze the possible connections between fat tissue and the quality of the skeleton in order to reduce related risks of the consequence of weight loss in obese individuals.
Study Overview
Detailed Description
The complex consequences of childhood obesity represent major concerns in most developed countries, largely contributing to metabolic complications with costly repercussions for the burden of disease. The burden is exemplified by high prevalence rates of overweight or obesity.
The ADIBOX protocol was designed to provide a better understanding of the bone-adipocyte cross-talk in adolescents with obesity and the effects of physical activity-induced weight loss on this cross-talk.
Obesity effectively leads to hormonal alterations favoring the accumulation of fat mass and loss of bone mass. Advancing the knowledge of the complex interactions between adipocyte and osteocyte activities may contribute to the mechanistic understanding of the body's responses to weight loss during adolescence and prevent cardiovascular risk. Indeed, the adipose-bone tissue cross-talk has been recently linked with cardiovascular diseases. Similarly as adipose tissue, released-products from bone tissue may act directly or indirectly on cardiovascular risk and diseases.
The ADIBOX study, a 40 weeks longitudinal study (LS) with repeated measures on four occasions (baseline and every fourteen weeks), will allow us to understand the effects of physical activity-induced weight loss on this cross-talk in obese adolescents.
Data will be analyzed using Stata (StataCorp, College Station, USA) and IBM Statistics SPSS version 22 (IBM Corp, 2013, Chicago, IL, USA) and significance will be accepted at a two-sided alpha level of p<0.05. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions.
Student t tests or Mann-Whitney U test will be performed to compare adipose tissue (total, subcutaneous, visceral) variation reported to bone mass variation at lumbar spine between groups at baseline. Pearson (or Spearman when appropriate) correlation coefficient will be used and compared with Fisher test (command corcor Stata) to measure the link between exercise-inducing weight loss on adipose tissue and bone mass variations. Longitudinal data will be treated using a mixed model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Recruiting
- CHU Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All adolescent girls will have to be free of any recent history of hospitalization (past two years) or of systemic illness lasting more than two weeks in the past 12 months. .
Exclusion Criteria:
- pregnant girl
- diabetes
- insulin-resistance
- hypo or hyper-thyroid
- consuming alcohol
- smokers
Study Plan
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
an intervention group who will undergo the management program combining physical activity and restrictive diet at Tza Nou Medical House for 10 months
|
|
|
Other: a control group
a control group who will not undergo any intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change from baseline fat mass measured by Dual energy X-ray Absorptiometry (DXA)
Time Frame: at 10 months.
|
at 10 months.
|
|
change from baseline bone mass measured by Dual energy X-ray Absorptiometry (DXA)
Time Frame: at 10 months
|
at 10 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Whole body measured by Dual energy X-ray Absorptiometry (DXA)
Time Frame: at 10 months
|
at 10 months
|
|
weight waist
Time Frame: at 10 months.
|
at 10 months.
|
|
waist circumference
Time Frame: at 10 months.
|
at 10 months.
|
|
lower limb bone lengths
Time Frame: at 10 months.
|
at 10 months.
|
|
Physical activity measured with International Physical Activity Questionnaire
Time Frame: at 10 months.
|
at 10 months.
|
|
Tanner's stages model for pubertal maturation
Time Frame: at 10 months.
|
at 10 months.
|
|
Energy metabolism assessed by cycle-ergometer submaximal aerobic fitness
Time Frame: at 10 months.
|
at 10 months.
|
|
bone mineral density measured by Peripheral Quantitative Computed Tomography
Time Frame: at 10 months.
|
at 10 months.
|
|
bone mineral status measured by Quantitative Ultra-Sound (QUS) on the non-dominant calcaneus.
Time Frame: at 10 months.
|
at 10 months.
|
|
Endocrine assays
Time Frame: at 10 months.
|
at 10 months.
|
|
Adolescents' observance to the weight loss lifestyle program
Time Frame: at 10 months
|
at 10 months
|
|
Metabolomics analysis in blood plasma
Time Frame: at 10 months
|
at 10 months
|
|
Ex-vivo mechanistic analysis
Time Frame: at 10 months
|
at 10 months
|
|
left ventricular end diastolic diameter measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
left ventricular end systolic diameter measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
posterior wall thickness measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
interventricular septum thickness measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
left ventricular mass indexed measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
left ventricular ejection fraction measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
valves velocity measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
isovolumic relaxation time measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
strain rate measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
myocardial dyssynchrony measured by echocardiography
Time Frame: at 10 months
|
at 10 months
|
|
carotid-intima-media thickness measured by echography
Time Frame: at 10 months
|
at 10 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-0249
- 2015-A01024-45 (Registry Identifier: 2015-A01024-45)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on weight loss
-
University of VermontUniversity of Vermont Medical CenterCompletedBreast Cancer | Overweight | PostmenopausalUnited States
-
University of PittsburghCompleted
-
VA Office of Research and DevelopmentTerminatedOverweight | Obstructive Sleep ApneaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
University of TennesseeCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Cigarette Restitution FundCompletedKidney Cancer | Breast Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Melanoma (Skin) | Gallbladder CancerUnited States
-
Boston Children's HospitalUniversity of Alabama at Birmingham; Indiana University; Baylor University; Framingham...Terminated
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
University of VermontUniversity of South Carolina; University of TennesseeCompleted